Top Taiwan Venture Capital Group independently manages funds exceeding NT$12 billion and assists the National Development Fund, the Industrial Development Bureau, and the Small and Medium Enterprise Administration in investing and supporting domestic companies. CID focuses on globally competitive businesses, internationally scalable services, China’s domestic-demand-driven sectors, as well as biopharma, new drugs, equipment, and distribution services within the biotech and healthcare industries, along with other innovative growth-oriented businesses.

WI Harper Group, established in 1993, is a U.S.-based venture capital firm specializing in early- and growth-stage investments. It currently manages eight venture funds with nearly US$1 billion in assets under management. Its investment focus lies in high-tech, digital new media (TMT), and healthcare, with a track record of over 350 portfolio companies and more than 80 successful IPO and M&A exits.

Founded in 1979, ITIC has invested in countless startups both domestically and internationally, supporting healthy growth for its portfolio companies. It spans multiple stages of startups and enterprises and integrates possibilities across industries, creating unique opportunities in tech venture capital thanks to its decades of technical expertise and global network.

Established by Taiwan’s National Development Council with private sector support, Taiwania Capital Management Corporation aims to boost domestic investment and economic growth. The firm has currently raised two funds: the “New Technology Fund (Taiwania Buffalo)” and the “Biotech & Medical Fund (Taiwania Buffalo II).”